169 related articles for article (PubMed ID: 37632288)
1. Detection of High-Risk Paraneoplastic Antibodies against TRIM9 and TRIM67 Proteins.
Bartley CM; Ngo TT; Do LD; Zekeridou A; Dandekar R; Muñiz-Castrillo S; Alvarenga BD; Zorn KC; Tubati A; Pinto AL; Browne WD; Hullett PW; Terrelonge M; Schubert RD; Piquet AL; Yang B; Montalvo M; Kung AF; Mann SA; Shah MP; Geschwind MD; Gelfand JM; DeRisi JL; Pittock SJ; Honnorat J; Pleasure SJ; Wilson MR
Ann Neurol; 2023 Dec; 94(6):1086-1101. PubMed ID: 37632288
[TBL] [Abstract][Full Text] [Related]
2. TRIM9 and TRIM67 Are New Targets in Paraneoplastic Cerebellar Degeneration.
Do LD; Gupton SL; Tanji K; Bastien J; Brugière S; Couté Y; Quadrio I; Rogemond V; Fabien N; Desestret V; Honnorat J
Cerebellum; 2019 Apr; 18(2):245-254. PubMed ID: 30350014
[TBL] [Abstract][Full Text] [Related]
3. Characterisation of TRIM46 autoantibody-associated paraneoplastic neurological syndrome.
Valencia-Sanchez C; Knight AM; Hammami MB; Guo Y; Mills JR; Kryzer TJ; Piquet AL; Amin A; Heinzelmann M; Lucchinetti CF; Lennon VA; McKeon A; Pittock SJ; Dubey D
J Neurol Neurosurg Psychiatry; 2022 Feb; 93(2):196-200. PubMed ID: 34921120
[TBL] [Abstract][Full Text] [Related]
4. Paraneoplastic cerebellar syndromes associated with antibodies against Purkinje cells.
Schwenkenbecher P; Chacko L; Pul R; Sühs KW; Wegner F; Wurster U; Stangel M; Skripuletz T
Int J Neurosci; 2018 Aug; 128(8):721-728. PubMed ID: 29199513
[TBL] [Abstract][Full Text] [Related]
5. The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis.
Menon S; Goldfarb D; Ho CT; Cloer EW; Boyer NP; Hardie C; Bock AJ; Johnson EC; Anil J; Major MB; Gupton SL
Mol Biol Cell; 2021 Feb; 32(4):314-330. PubMed ID: 33378226
[TBL] [Abstract][Full Text] [Related]
6. Paraneoplastic Cerebellar Degeneration: The Importance of Including CDR2L as a Diagnostic Marker.
Herdlevær I; Haugen M; Mazengia K; Totland C; Vedeler C
Neurol Neuroimmunol Neuroinflamm; 2021 Mar; 8(2):. PubMed ID: 33531379
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of TRIM9 attenuates irinotecan‑induced intestinal mucositis in IEC‑6 cells by regulating DUSP6 expression via the P38 pathway.
Zhao W; Wang Q
Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34676875
[TBL] [Abstract][Full Text] [Related]
8. A cerebellar degeneration-related protein 2-like cell-based assay for anti-Yo detection in patients with paraneoplastic cerebellar degeneration.
Erikstad KI; Herdlevaer I; Peter E; Haugen M; Totland C; Vedeler C
Eur J Neurol; 2023 Jun; 30(6):1727-1733. PubMed ID: 36912432
[TBL] [Abstract][Full Text] [Related]
9. Inositol 1,4,5-trisphosphate receptor type 1 autoantibodies in paraneoplastic and non-paraneoplastic peripheral neuropathy.
Jarius S; Ringelstein M; Haas J; Serysheva II; Komorowski L; Fechner K; Wandinger KP; Albrecht P; Hefter H; Moser A; Neuen-Jacob E; Hartung HP; Wildemann B; Aktas O
J Neuroinflammation; 2016 Oct; 13(1):278. PubMed ID: 27776522
[TBL] [Abstract][Full Text] [Related]
10. Qualitative evidence of anti-Yo-specific intrathecal antibody synthesis in patients with paraneoplastic cerebellar degeneration.
Stich O; Graus F; Rasiah C; Rauer S
J Neuroimmunol; 2003 Aug; 141(1-2):165-9. PubMed ID: 12965268
[TBL] [Abstract][Full Text] [Related]
11. Glial fibrillary acidic protein immunoglobulin G as biomarker of autoimmune astrocytopathy: Analysis of 102 patients.
Flanagan EP; Hinson SR; Lennon VA; Fang B; Aksamit AJ; Morris PP; Basal E; Honorat JA; Alfugham NB; Linnoila JJ; Weinshenker BG; Pittock SJ; McKeon A
Ann Neurol; 2017 Feb; 81(2):298-309. PubMed ID: 28120349
[TBL] [Abstract][Full Text] [Related]
12. Identification of SKOR2 IgG as a novel biomarker of paraneoplastic neurologic syndrome.
Rezk M; Pittock SJ; Kapadia RK; Knight AM; Guo Y; Gupta P; LaFrance-Corey RG; Zekeridou A; McKeon A; Dasari S; Mills JR; Dubey D
Front Immunol; 2023; 14():1243946. PubMed ID: 37795104
[TBL] [Abstract][Full Text] [Related]
13. Anti-Yo antibody uptake and interaction with its intracellular target antigen causes Purkinje cell death in rat cerebellar slice cultures: a possible mechanism for paraneoplastic cerebellar degeneration in humans with gynecological or breast cancers.
Greenlee JE; Clawson SA; Hill KE; Wood B; Clardy SL; Tsunoda I; Carlson NG
PLoS One; 2015; 10(4):e0123446. PubMed ID: 25885452
[TBL] [Abstract][Full Text] [Related]
14. Antibodies to Delta/notch-like epidermal growth factor-related receptor in patients with anti-Tr, paraneoplastic cerebellar degeneration, and Hodgkin lymphoma.
Greene M; Lai Y; Baella N; Dalmau J; Lancaster E
JAMA Neurol; 2014 Aug; 71(8):1003-8. PubMed ID: 24935874
[TBL] [Abstract][Full Text] [Related]
15. Paraneoplastic Cerebellar Degeneration With P/Q-VGCC vs Yo Autoantibodies.
Winklehner M; Bauer J; Endmayr V; Schwaiger C; Ricken G; Motomura M; Yoshimura S; Shintaku H; Ishikawa K; Tsuura Y; Iizuka T; Yokota T; Irioka T; Höftberger R
Neurol Neuroimmunol Neuroinflamm; 2022 Jul; 9(4):. PubMed ID: 36070310
[TBL] [Abstract][Full Text] [Related]
16. Microtubule-associated protein 1B: Novel paraneoplastic biomarker.
Gadoth A; Kryzer TJ; Fryer J; McKeon A; Lennon VA; Pittock SJ
Ann Neurol; 2017 Feb; 81(2):266-277. PubMed ID: 28074593
[TBL] [Abstract][Full Text] [Related]
17. CDR2L Is the Major Yo Antibody Target in Paraneoplastic Cerebellar Degeneration.
Kråkenes T; Herdlevaer I; Raspotnig M; Haugen M; Schubert M; Vedeler CA
Ann Neurol; 2019 Aug; 86(2):316-321. PubMed ID: 31148214
[TBL] [Abstract][Full Text] [Related]
18. Update in Autoimmune Movement Disorders: Newly Described Antigen Targets in Autoimmune and Paraneoplastic Cerebellar Ataxia.
Garza M; Piquet AL
Front Neurol; 2021; 12():683048. PubMed ID: 34489848
[TBL] [Abstract][Full Text] [Related]
19. GRP78 antibodies damage the blood-brain barrier and relate to cerebellar degeneration in Lambert-Eaton myasthenic syndrome.
Shimizu F; Takeshita Y; Sano Y; Hamamoto Y; Shiraishi H; Sato T; Yoshimura S; Maeda T; Fujikawa S; Nishihara H; Kitanosono H; Tsujino A; Motomura M; Kanda T
Brain; 2019 Aug; 142(8):2253-2264. PubMed ID: 31236596
[TBL] [Abstract][Full Text] [Related]
20. Leucine Zipper 4 Autoantibody: A Novel Germ Cell Tumor and Paraneoplastic Biomarker.
Dubey D; Kryzer T; Guo Y; Clarkson B; Cheville JC; Costello BA; Leibovich BC; Algeciras-Schimnich A; Lucchinnetti C; Hammami MB; Knight AM; Howe C; Lennon VA; McKeon A; Pittock SJ
Ann Neurol; 2021 May; 89(5):1001-1010. PubMed ID: 33583072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
